Pancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN): emerging data warrants further research.
作者信息
Lucocq James, Pandanaboyana Sanjay
机构信息
Department of Hepatopancreatobiliary Surgery, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK.
Department of HPB and Transplant Surgery, Freeman Hospital, Newcastle, UK.
出版信息
Br J Surg. 2024 Oct 1;111(10). doi: 10.1093/bjs/znae238.
Abstract
摘要
相似文献
1
Pancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN): emerging data warrants further research.
Br J Surg. 2024 Oct 1;111(10). doi: 10.1093/bjs/znae238.
2
Invasive intraductal oncocytic papillary neoplasms (IOPN) and adenocarcimoma arising from intraductal papillary mucinous neoplasms (A-IPMN) of the pancreas: comparative analysis of clinicopathological features, patterns of recurrence and survival: a multicentre study.
HPB (Oxford). 2024 Nov;26(11):1421-1428. doi: 10.1016/j.hpb.2024.07.410. Epub 2024 Jul 20.
3
Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm and derivation of a prognostic model: An international multicenter study (ADENO-IPMN study).
Surgery. 2024 Sep;176(3):890-898. doi: 10.1016/j.surg.2024.05.010. Epub 2024 Jun 25.
4
Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study).
Ann Surg. 2024 Jul 1;280(1):126-135. doi: 10.1097/SLA.0000000000006144. Epub 2023 Oct 24.
5
A Practical Strategy to Reduce Surgical Overtreatment of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Ann Surg. 2024 Jul 1;280(1):32-34. doi: 10.1097/SLA.0000000000006133. Epub 2023 Oct 17.
6
[A rare case of intraductal tumor of the pancreas in which an intraductal tubulopapillary neoplasm was mixed with a widely spreading gastric-type intraductal papillary-mucinous neoplasm].
Nihon Shokakibyo Gakkai Zasshi. 2024;121(5):415-424. doi: 10.11405/nisshoshi.121.415.
7
A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation.
Langenbecks Arch Surg. 2022 Dec;407(8):3447-3455. doi: 10.1007/s00423-022-02687-2. Epub 2022 Oct 6.
8
Long-term survival after resection of invasive pancreatic intraductal papillary mucinous neoplasm.
Langenbecks Arch Surg. 2024 Nov 26;409(1):361. doi: 10.1007/s00423-024-03550-2.
9
Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Pancreas. 2013 Nov;42(8):1267-74. doi: 10.1097/mpa.0b013e3182954137.
10
Colloid Carcinoma of Pancreas in the Setting of Intraductal Papillary Mucinous Neoplasm (IPMN).
J Gastrointest Cancer. 2020 Jun;51(2):658-662. doi: 10.1007/s12029-019-00322-w.
本文引用的文献
1
Invasive intraductal oncocytic papillary neoplasms (IOPN) and adenocarcimoma arising from intraductal papillary mucinous neoplasms (A-IPMN) of the pancreas: comparative analysis of clinicopathological features, patterns of recurrence and survival: a multicentre study.
HPB (Oxford). 2024 Nov;26(11):1421-1428. doi: 10.1016/j.hpb.2024.07.410. Epub 2024 Jul 20.
2
Precursor Epithelial Subtypes of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms (A-IPMN): Clinicopathological Features, Recurrence and Response to Adjuvant Chemotherapy.
Ann Surg Oncol. 2024 Oct;31(10):7023-7032. doi: 10.1245/s10434-024-15677-z. Epub 2024 Jul 3.
3
Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm and derivation of a prognostic model: An international multicenter study (ADENO-IPMN study).
Surgery. 2024 Sep;176(3):890-898. doi: 10.1016/j.surg.2024.05.010. Epub 2024 Jun 25.
4
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study.
Br J Surg. 2024 Apr 3;111(4). doi: 10.1093/bjs/znae100.
5
Long-term Outcomes following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched Analysis.
Ann Surg. 2024 Mar 22. doi: 10.1097/SLA.0000000000006272.
6
Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study).
Ann Surg. 2024 Jul 1;280(1):126-135. doi: 10.1097/SLA.0000000000006144. Epub 2023 Oct 24.
7
Artificial intelligence-based models to assess the risk of malignancy on radiological imaging in patients with intraductal papillary mucinous neoplasm of the pancreas: scoping review.
Br J Surg. 2023 Nov 9;110(12):1623-1627. doi: 10.1093/bjs/znad201.
8
Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential.
Cancer Discov. 2023 Aug 4;13(8):1844-1861. doi: 10.1158/2159-8290.CD-22-1200.
9
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study.
Br J Surg. 2020 Aug;107(9):1171-1182. doi: 10.1002/bjs.11555. Epub 2020 Apr 7.
Zotero 插件